17-62391831-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173503.4(EFCAB3):āc.161A>Gā(p.Asp54Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173503.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFCAB3 | NM_173503.4 | c.161A>G | p.Asp54Gly | missense_variant | 4/10 | ENST00000305286.8 | NP_775774.1 | |
EFCAB3 | NM_001144933.2 | c.317A>G | p.Asp106Gly | missense_variant | 6/12 | NP_001138405.1 | ||
EFCAB3 | XM_011524381.3 | c.227A>G | p.Asp76Gly | missense_variant | 4/10 | XP_011522683.2 | ||
EFCAB3 | XM_011524380.2 | c.161A>G | p.Asp54Gly | missense_variant | 4/10 | XP_011522682.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFCAB3 | ENST00000305286.8 | c.161A>G | p.Asp54Gly | missense_variant | 4/10 | 1 | NM_173503.4 | ENSP00000302649 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251216Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135776
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461278Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726960
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.317A>G (p.D106G) alteration is located in exon 6 (coding exon 6) of the EFCAB3 gene. This alteration results from a A to G substitution at nucleotide position 317, causing the aspartic acid (D) at amino acid position 106 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at